Whats less often discussed is that the number on the scale doesnt tell the full story
Some versions, like semaglutide , have a half-life of about a week, which is why they only require once-weekly dosing
Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis
Studies have shown that users on the highest dose lost an average of 20.9% of their body weight, making it a strong consideration for those facing significant weight loss challenges
And if at this particular time, you launch, you will be lost somewhere. Rajeev Juneja, Vice Chairman & MD, Mankind Pharma | Q4 FY26 I am not going to tell you that we are going to make a lot of money in India, I will never say that, I actually agree with you, it will be very competitive. Rajeev Nannapaneni, Vice Chairman & CEO, Natco Pharma | Q2 FY26 So why run it anyway